Previous studies have reported that NETs accentuate cancer growth through the activation of the NF-κB and MAP kinase signaling cascade [39–41] and potentiate metastatic capacity by multiple effects, including cancer cell mobility, circulating tumor cell adhesion and promoting metastatic growth within the metastatic niche [42]. The gene discussed is NFKB1; the disease is cancer.